Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Healthcare Biotechnology
Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency... see more

Recent & Breaking News (TSX:MBX)

Microbix Achieves Further QAPs Sales Record

GlobeNewswire January 3, 2024

Microbix Reports Results for Q4 & Full-Year Fiscal 2023

GlobeNewswire December 21, 2023

Microbix & Seegene USA Jointly Enhancing Lab Test Accuracy

GlobeNewswire December 14, 2023

Microbix & BioGX Collaborate on real-time PCR Assays & Controls

GlobeNewswire December 7, 2023

Microbix Announces Initiation of Normal Course Issuer Bid

GlobeNewswire December 6, 2023

Microbix Presenting at Florida Capital Event Conference

GlobeNewswire November 17, 2023

Microbix Clot-Buster Drug Fully-Funded For Return to U.S. Market

GlobeNewswire November 16, 2023

Microbix & Ulisse Biomed Collaborate on HPV Controls & Assays

GlobeNewswire November 10, 2023

Microbix QAPs Supporting HPV Testing in Ireland

GlobeNewswire October 27, 2023

Microbix Presenting at Muskoka Capital Conference

GlobeNewswire September 29, 2023

Microbix Achieves New QAPs Sales Record

GlobeNewswire September 27, 2023

Microbix Honours the Passing of its Founder

GlobeNewswire September 13, 2023

Microbix Reports Results for Q3 Fiscal 2023

GlobeNewswire August 10, 2023

Microbix Successfully Upgrades Logistics Software Systems Achieves "Go-Live" with New ERP and eQMS Solutions

GlobeNewswire August 4, 2023

Microbix Presents Results of STI Test Controls at AACC

GlobeNewswire July 24, 2023

Microbix QAPs Supporting HPV Testing Across The Netherlands

GlobeNewswire July 5, 2023

Microbix & Labquality Create Novel Testing Accreditation Program

GlobeNewswire June 20, 2023

Microbix Presents Results of STI Test Controls at ASM Microbe

GlobeNewswire June 13, 2023

Microbix Announces Extension of Warrant Expiry Date

GlobeNewswire May 18, 2023

Microbix Secures Funded Drug Commercialization Agreement

GlobeNewswire May 16, 2023